The final, formatted version of the article will be published soon.
MINI REVIEW article
Front. Digit. Health
Sec. Connected Health
Volume 6 - 2024 |
doi: 10.3389/fdgth.2024.1484503
This article is part of the Research Topic Proceedings of the Bridge2AI Voice Symposium 2024 View all articles
Keynote Speeches of the 2024 Voice AI Symposium, presented by the Bridge2AI-Voice Consortium
Provisionally accepted- 1 Northeastern University, Boston, Massachusetts, United States
- 2 University of Michigan, Ann Arbor, Michigan, United States
- 3 University of South Florida, Tampa, United States
- 4 Oregon Health and Science University, Portland, Oregon, United States
- 5 Simon Fraser University, Burnaby, British Columbia, Canada
- 6 Washington University in St. Louis, St. Louis, Missouri, United States
- 7 Vanderbilt University Medical Center, Nashville, Tennessee, United States
- 8 Weill Cornell Medicine, Cornell University, New York, New York, United States
Introduction: The 2024 Voice AI Symposium, hosted by the Bridge2AI-Voice Consortium in Tampa, FL, featured two keynote speeches that addressed the intersection of voice AI, healthcare, ethics, and law. Dr. Rupal Patel and Dr. Nicholson Price provided insights into the advancements, applications, and challenges of AI-driven voice tools in healthcare. The symposium aimed to advance cross-disciplinary collaboration and establish frameworks for the ethical use of AI technologies in healthcare. Methods: The keynote speeches, delivered on May 1st and 2nd, were 30 minutes each, followed by 10-minute Q&A sessions. The audio was recorded and transcribed using Whisper (v7.13.1). Content summaries were generated with the aid of ChatGPT (v4.0), and the authors reviewed and edited the final transcripts to ensure accuracy and clarity. Results: Dr. Rupal Patel’s keynote, "Reflections and New Frontiers in Voice AI," explored the potential of voice AI for early detection of health conditions, monitoring disease progression, and promoting non-invasive global health management. She highlighted innovative uses beyond traditional applications, such as examining menopause-related symptoms. Dr. Nicholson Price’s keynote, "Governance for Clinical Voice AI," addressed the regulatory and ethical challenges posed by AI in healthcare. He stressed the need for context-aware systems and dynamic legal frameworks to address liability and accountability. Conclusions: The 2024 Voice AI Symposium highlighted the transformative potential of voice AI for early detection, health monitoring, and reducing healthcare disparities. It also underscored the importance of dynamic governance to address the ethical and regulatory challenges of deploying AI in clinical settings.
Keywords: artificial intelligence, audiomics, Voice biomarkers, Bridge2AI, Bridge2AI-Voice
Received: 21 Aug 2024; Accepted: 31 Oct 2024.
Copyright: © 2024 Patel, Price, Bahr, Bedrick, Bensoussan, Bélisle-Pipon, Dorr, Jackson, Krussel, Salvi Cruz, Toghranegar, Watts, Zhao and Powell. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jamie Toghranegar, University of South Florida, Tampa, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.